Carlyle
Latest statistics and disclosures from Carlyle Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MDLN, SARO, PHAT, PONY, INVH, and represent 99.74% of Carlyle Group's stock portfolio.
- Added to shares of these 5 stocks: MDLN (+$9.0B), INVH (+$5.2M), ACET, HOOD, SYRE.
- Started 4 new stock positions in ACET, MDLN, HOOD, SYRE.
- Reduced shares in these 4 stocks: SPRB (-$244M), Adicet Bio, SPWR, XCUR.
- Sold out of its position in Adicet Bio.
- Carlyle Group was a net buyer of stock by $8.8B.
- Carlyle Group has $14B in assets under management (AUM), dropping by 212.77%.
- Central Index Key (CIK): 0001527166
Tip: Access up to 7 years of quarterly data
Positions held by Carlyle consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Carlyle Group
Carlyle Group holds 20 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Medline Com Cl A (MDLN) | 66.7 | $9.0B | NEW | 215M | 42.00 |
|
| Standardaero (SARO) | 32.3 | $4.4B | 153M | 28.68 |
|
|
| Phathom Pharmaceuticals (PHAT) | 0.4 | $58M | 3.5M | 16.58 |
|
|
| Pony Ai Sponsored Ads (PONY) | 0.3 | $34M | 2.4M | 14.50 |
|
|
| Invitation Homes (INVH) | 0.1 | $19M | +39% | 664k | 27.79 |
|
| Getty Images Holdings Cl A Com (GETY) | 0.1 | $8.4M | 6.2M | 1.34 |
|
|
| Cubesmart (CUBE) | 0.1 | $7.9M | 221k | 36.05 |
|
|
| Q32 Bio (QTTB) | 0.0 | $3.6M | 1.1M | 3.28 |
|
|
| Spruce Biosciences Com New (SPRB) | 0.0 | $3.3M | -98% | 39k | 85.42 |
|
| Forward Air Corp (FWRD) | 0.0 | $3.1M | 107k | 28.85 |
|
|
| Jasper Therapeutics Com New (JSPR) | 0.0 | $1.9M | 1.1M | 1.82 |
|
|
| Adicet Bio Com New (ACET) | 0.0 | $1.5M | NEW | 184k | 8.38 |
|
| Krispy Kreme (DNUT) | 0.0 | $1.4M | 341k | 4.02 |
|
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.0 | $772k | 270k | 2.86 |
|
|
| N-able Common Stock (NABL) | 0.0 | $701k | 94k | 7.48 |
|
|
| Complete Solaria (SPWR) | 0.0 | $680k | -65% | 433k | 1.57 |
|
| Nucana Sponsored Ads (NCNA) | 0.0 | $480k | 133k | 3.60 |
|
|
| Robinhood Mkts Com Cl A (HOOD) | 0.0 | $382k | NEW | 3.4k | 113.10 |
|
| Spyre Therapeutics Com New (SYRE) | 0.0 | $315k | NEW | 9.6k | 32.75 |
|
| Exicure (XCUR) | 0.0 | $305k | -79% | 56k | 5.41 |
|
Past Filings by Carlyle Group
SEC 13F filings are viewable for Carlyle Group going back to 2012
- Carlyle Group 2025 Q4 filed Feb. 13, 2026
- Carlyle Group 2025 Q3 filed Nov. 7, 2025
- Carlyle Group 2025 Q2 filed Aug. 8, 2025
- Carlyle Group 2025 Q1 filed May 9, 2025
- Carlyle Group 2024 Q4 filed Feb. 13, 2025
- Carlyle Group 2024 Q3 filed Nov. 8, 2024
- Carlyle Group 2024 Q2 filed Aug. 9, 2024
- Carlyle Group 2024 Q1 filed May 3, 2024
- Carlyle Group 2023 Q4 filed Feb. 2, 2024
- Carlyle Group 2023 Q3 filed Nov. 3, 2023
- Carlyle Group 2023 Q2 filed Aug. 4, 2023
- Carlyle Group 2023 Q1 filed May 5, 2023
- Carlyle Group 2022 Q4 filed Feb. 10, 2023
- Carlyle Group 2022 Q3 filed Nov. 10, 2022
- Carlyle Group 2022 Q2 filed Aug. 12, 2022
- Carlyle Group 2022 Q1 filed May 13, 2022